insights_auto
Why is NEO down 2,03%?
Dive Deeperchevron_right
NEO:NASDAQ
NeoGenomics, Inc.
18,36 $
arrow_downward
-2,03%(-0,38) 1D
18,63 $
arrow_upward
+1,47% (+0,27)bedtimeAfter hours
Closed: 30 սեպ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
18,76 $
High
18,96 $
Low
18,28 $
Mkt. cap
2,36 մլրդ
Avg. vol.
1,96 մլն
Volume
0,00
52-wk high
20,05 $
52-wk low
7,06 $
EPS
-0,40 $
Beta
1,75
Shares outstanding
128,48 մլն
No. of employees
2 հզր
Open
18,76 $
High
18,96 $
Low
18,28 $
Mkt. cap
2,36 մլրդ
Avg. vol.
1,96 մլն
Volume
0,00
52-wk high
20,05 $
52-wk low
7,06 $
EPS
-0,40 $
Beta
1,75
Shares outstanding
128,48 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
NEWS10 ABC
·
2 ժամ առաջ
Asian shares mostly rise amid market optimism about AI, despite Iran worries
Simply Wall Street
·
54 րոպե առաջ
Learn Why The Bull Case For Amplitude (AMPL) Could Change Following Earnings Beat
AD HOC NEWS
·
6 րոպե առաջ
CVGW stock exits Nasdaq after Mission Produce deal
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2,5 հզր
Founded2002
HeadquartersՖորտ Մայերս, Ֆլորիդա, Միացյալ Նահանգներ
SectorHealth care provider
Websiteneogenomics.com